Tianjin Pharmaceutical Da Ren Tang Co., Ltd. logo

Tianjin Pharmaceutical Da Ren Tang Co., Ltd. (600329)

Market Open
11 Aug, 06:57
SSE SSE
¥
37. 35
+0.14
+0.3762%
¥
22.62B Market Cap
- P/E Ratio
0.6% Div Yield
777,500 Volume
- Eps
¥ 37.21
Previous Close
Add Transaction
Day Range
37 37.48
Year Range
34.7 50.97
Want to track 600329 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600329 trading today higher at ¥37.35, an increase of 0.3762% from yesterday's close, completing a monthly increase of 0.5384% or ¥0.2. Over the past 12 months, 600329 stock lost -18.146%.
600329 pays dividends to its shareholders, with the most recent payment made on Jul 10, 2026. The next estimated payment will be in In 4 months on Jan 10, 2027 for a total of ¥2.34.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Tianjin Pharmaceutical Da Ren Tang Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jul 05, 2010.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on SSE (CNY).

600329 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.47
-0.0954%
Seres Group Co., Ltd.
¥ 55.54
-0.8745%
Great Wall Motor Co., Ltd.
¥ 15.68
-0.0637%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.5
-0.159%
China Tourism Group Duty Free Corporation Limited
¥ 56.02
-0.3912%

Tianjin Pharmaceutical Da Ren Tang Co., Ltd. (600329) FAQ

What is the stock price today?

The current price is ¥37.35.

On which exchange is it traded?

Tianjin Pharmaceutical Da Ren Tang Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600329.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, the market cap is 22.62B.

Has Tianjin Pharmaceutical Da Ren Tang Co., Ltd. ever had a stock split?

Tianjin Pharmaceutical Da Ren Tang Co., Ltd. had 2 splits and the recent split was on Jul 05, 2010.

Tianjin Pharmaceutical Da Ren Tang Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Lei Wang CEO
SSE Exchange
CNE000001808 ISIN
China Country
4,619 Employees
12 Feb 2026 Last Dividend
5 Jul 2010 Last Split
- IPO Date

Overview

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, a comprehensive entity that encompasses a wide array of activities within the pharmaceutical industry, marks its presence predominantly within the People’s Republic of China. The company’s operations span across the production and distribution of traditional Chinese medicine (TCM) and Western medicine, reflecting a synergistic blend of ancient practices and modern pharmacology. Established in 1981 and rooted in Tianjin, this conglomerate has expanded its portfolio to include chemical raw materials, pharmaceutical preparations, and biomedical products, thereby catering to a broad spectrum of healthcare needs. In May 2022, it underwent a significant rebranding from its former identity as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, indicating a strategic pivot or expansion in its business model. Besides its manufacturing prowess, the company is also actively involved in the wholesale and retail sectors of the medicine market, alongside offering pharmaceutical commercial logistic services.

Products and Services

  • Suxiao Jiuxin Pills: A renowned traditional Chinese medicine product designed for the treatment of heart-related ailments.

  • Jingwanhong Ointment: This ointment is used primarily for its healing properties in treating burns, wounds, and skin ulcers.

  • Biqi Capsules: Aimed at alleviating pain and discomfort associated with rheumatism and arthritis.

  • Shunaoxin Dropping Pills: Developed to enhance cardiovascular health, these pills address cerebrovascular conditions.

  • Zilongjin Tablets: These tablets are used in the management of various cancer conditions, supporting traditional cancer treatments.

  • Qingfei Xiaoyan Pills: Intended for respiratory conditions, these pills help in clearing heat and detoxifying the lungs.

  • Huoxiangzhengqi Soft Capsules: Used primarily for gastrointestinal discomfort, these capsules aid in digestion and relieve symptoms of food poisoning.

  • Tongmai Yangxin Pills: Targets cardiovascular diseases, promoting heart health and improving circulation.

  • Weichangan Pills: These pills are focused on improving gastrointestinal health and function.

  • Qingyan Dropping Pills: Designed for throat health, these pills relieve sore throat and hoarseness.

  • Haima Bushen Pills: Focused on kidney health, these pills are used in traditional treatments for enhancing vitality and energy.

  • Angong Niuhuang Pills: A critical care TCM product, used in treatments of high fever, convulsions, and strokes.

  • Niuhuang Qingxin Pills: Similar to Angong Niuhuang Pills, these are used for heart and brain health, particularly in acute conditions.

  • Qinggong Shoutao Pills: Aimed at promoting longevity and enhancing overall wellness, based on TCM principles.

In addition to the aforementioned pharmaceutical products, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited delves into commercial logistics services within the pharmaceutical realm. This encompasses a comprehensive suite of offerings aimed at optimizing the supply chain and distribution channels for pharmaceuticals, thus ensuring efficient and timely delivery of medical products. Additionally, the company’s involvement in chemical raw materials and preparations, along with biomedicine, broadens its scope and capacity to contribute significantly to the health sector, both nationally and potentially internationally.

Contact Information

Address: Darentang Building
Phone: 86 22 2702 0598